Wife oral health care products by Joincare hind legs dragging
21shijijingjibaodao· 2017-08-29 10:02:57
" Beijing daily news (reporter Sun Qixiang Wang Xiaoli) health products drag Joincare Pharmaceutical Group Limited by Share Ltd (hereinafter referred to as the "health") after the performance of the leg. Newly released Joincare 2017 semi annual report, the company health care products and OTC business declined, the company's first revenue sources of chemical agents. Data show that the first half of 2017 yuan, achieved operating income of 5 billion 443 million yuan, an increase of 10.84% last year; net profit of 327 million yuan, an increase of 27.07% over the previous year; attributable to shareholders of listed companies net profit after deducting non recurring gains and losses of 290 million yuan, up 27.99% over the same period last year. The growth performance is mainly due to the subsidiary of Jiaozuo waterfront pharmaceutical, Joincare Franc Group sales revenue increase and.
, however, had been known to consumers health care products business in the poor performance of the overall performance of the territory: during the reporting period, the company health care products and OTC business (excluding Livzon Group OTC) sales revenue of 158 million yuan, down 18.72% over the same period last year; realize the contribution to net profit of 27 million yuan, down about 34.22% over the previous year over the same period.
this, Joincare said that the main reason for the decline in performance due to marketing and promotion activities reduce the efficiency of adjustment. With the recent media price continued to decline, the company health care products has gradually changed the "ads + channel" mode to adjust the "channel + ground promotion mode, as competition intensifies, the efficiency is greatly reduced ground promotion activities. In addition, in 2015 began to vigorously layout of micro channel channels, due to changes in the industry environment and sales significantly decline, the new model has not yet come out of the exploration stage.
"wife", "meditation", "Eagle" brand health care products for Joincare had laid a good foundation of the brand, but now it has become the most poor part of the group's overall performance in. Beginning last year, the company's health care sector began to sluggish operation. Annual data show that last year, the health care revenue of 218 million yuan, year-on-year decline of 18.33% in 2015. The main reason is the decline in the performance of the company's health care business serious setback, and the thought of port group cooperation in health products sold in the micro channel business sales fell sharply, the revenues plummeting from 77 million 647 thousand and 600 yuan to 1 million 798 thousand and 800 yuan. In the last major shareholding enterprises in Joincare pharmaceutical, Mrs. operating income is 111 million yuan, 9 million 32 thousand and 700 yuan loss. According to the health care sector the future direction of development, the Beijing Daily reporter called Joincare secretaries office, but as of press time did not get a reply.
for the second half of the development of health care products, Joincare proposed in the semi annual report, will increase the electricity supplier, electricity providers and other new social channels open and promote efforts to accelerate the exploration of new model. At the same time, the strategy of deepening cooperation with drug line channels, locking up the existing vertical channel of healthy people, common health services to enhance the user experience, enhance customer loyalty, enhance brand loyalty and to enhance the performance of permeability.
however, from the current operating earnings data, new products did not give the health care sector to bring performance leap. Some analysts have pointed out that the wife oral liquid has just launched sales better, then Joincare did not extend the brand niche advantage, the sales decline. Will sell channels to micro business, if the product is not differentiated, may also be faced with the traditional line pharmacies channels competing dilemma.
Beijing medical industry fund co-founder Yue Feng said, from the category of health care products, foreign brands product line is generally more complete than local enterprises. "Wife" and other Chinese enterprises, product design is still more extensive, often lack of vitality of star products, as well as for different groups of products segmentation. In the early stages of health care market development, this approach can be as much as possible through a product of the customer base, conducive to rapid expansion of sales. But as the industry matures and demand segmentation, the "take all" product structure will gradually be targeted, customized products instead.